Influência do CD 20 na refratariedade do linfoma de Hodgkin clássico ao tratamento inicial com o esquema ABVD, no Ceará, Brasil Influence of CD 20 antigen expression in the refractoriness of classical Hodgkin lymphoma in the first line treatment with ABVD protocol in Ceará state, Brazil
INTRODUÇÃO: A significância prognóstica do marcador imunológico CD 20 no linfoma de Hodgkin clássico (LHc) ainda é incerta, particularmente no que se refere à refratariedade ao tratamento inicial. OBJETIVOS: Avaliar a influência da positividade do marcador CD 20 na refratariedade do LHc ao...
Saved in:
Main Authors: | Rogério Pinto Giesta (Author), Francisco Dário Rocha Filho (Author), Francisco Valdeci de Almeida Ferreira (Author), Acy Telles de Souza Quixadá (Author), Jorg Heukelbach (Author), Marília de Andrade Guedes Giesta (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Patologia Clínica,
2009-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report
by: Camille Cotteret, et al.
Published: (2020) -
Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
by: Min Hu, et al.
Published: (2023) -
Clinical profile and outcome of classical Hodgkin lymphoma treated with ABVD protocol at Homi Bhabha Cancer Hospital Varanasi
by: NIKITA SINGH, et al.
Published: (2022) -
CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
by: Ashish Jagati, et al.
Published: (2017) -
CD20 positivity in classical Hodgkin′s lymphoma: Diagnostic challenge or targeting opportunity
by: Barakzai Muhammad, et al.
Published: (2009)